T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies

Brain

Volumn 119, Issue 4, 1996, Pages 1079-1090

  Jung, Stefan ^a   Toyka, Klaus ^a   Hartung, Hans Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adhesion molecule; Antibody therapy; Autoimmune neuritis, experimental; Experimental autoimmune neuritis; Guillain Barre syndrome; T lymphocyte

Indexed keywords

CD2 ANTIGEN; MONOCLONAL ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFER; CLONAL ANERGY; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; DEMYELINATION; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; DRUG THERAPY; ELECTROPHYSIOLOGY; FEMALE; GUILLAIN BARRE SYNDROME; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE INJURY; NEURITIS; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

EID: 0029738924     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.4.1079     Document Type: Article

References (48)

1. Barlow AK, Like AA. Anti-CD2 monoclonal antibodies prevent spontaneous and adoptive transfer of diabetes in the BB/Wor rat. Am J Pathol 1992; 141: 1043-51.
2. Bierer BE, Hahn WC. T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2. [Review]. Semin Immunol 1993; 5: 249-61.
3. Bromberg JS, Chavin KD, Altevogt P, Kyewski BA, Guckel B, Naji A, et al. Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo. Transplantation 1991; 51: 219-25.
4. Brostoff SW, Mason DW. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J Immunol 1984; 133: 1938-42.
5. Caspi RR, Chan CC, Fujino Y, Najafian F, Grover S, Hanssen CT, et al. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis. J Neuroimmunol 1993; 47: 177-88.
6. Chavin KD, Lau HT, Bromberg JS. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies. Transplantation 1992; 54: 286-91.
7. Chavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects. Transplantation 1993; 55: 901-8.
8. Chavin KD, Qin L, Lin J, Yagita H, Bromberg JS. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donorspecific tolerance in a cardiac transplant model. J Immunol 1993; 151: 7249-59.
9. Clark SJ, Law DA, Paterson DJ, Puklavec M, Williams AF. Activation of rat T lymphocytes by anti-CD2 monoclonal antibodies. J Exp Med 1988; 167: 1861-72.
10. Dallman MJ, Thomas ML, Green JR. MRC OX-19: a monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses. Eur J Immunol 1984; 14: 260-7.
11. Dustin ML, Springer TA. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. [Review]. Annu Rev Immunol 1991; 9: 27-66.
12. Eylar EH, Kniskern PJ, Jackson JJ. Myelin basic proteins. Methods Enzymol 1974; 32: 323-41.
13. Gueckel B, Berek C, Lutz M, Altevogt P, Schirrmacher V, Kyewski BA. Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med 1991; 174: 957-67.
14. Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985; 35: 1096-104.
15. Hahn AF, Feasby TE, Wilkie L, Lovgren D. P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration. Acta Neuropathol (Berl) 1991; 82: 60-5.
16. Hartung H-P, Heininger K, Schäfer B, Fierz W, Toyka KV. Immune mechanisms in inflammatory polyneuropathy. [Review]. Ann NY Acad Sci 1988a; 540: 122-61.
17. Hartung HP, Schäfer B, Heininger K, Stoll G, Toyka KV. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations. Brain 1988b; 111: 1039-59.
18. Hartung HP, Schaefer B, Diamantstein T, Fierz W, Heininger K, Toyka KV. Suppression of P2-T cell line-mediated experimental autoimmune neuritis by interleukin-2 receptor targeted monoclonal antibody ART 18. Brain Res 1989; 489: 120-8.
19. Hartung HP, Stoll G, Toyka KV. Immune reactions in the peripheral nervous system. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. 3rd ed. Philadelphia: W.B. Saunders, 1993: 418-44.
20. Hathcock KS. T cell enrichment by nonadherence to nylon wool. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, Coico R, editors.Current protocols in immunology. New York: John Wiley, 1994: 3.2.1-5.
21. Huenig T, Tiefenthaler G, Meyer zum Büschenfelde K-H, Meuer SC. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand. Nature 1987; 326: 298-301.
22. Huenig T, Wallny H-J, Hartley JK, Lawetzky A, Tiefenthaler G. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J Exp Med 1989; 169: 73-86.
23. Hughes RAC. Guillain-Barré syndrome. London: Springer-Verlag, 1990.
24. Jefferies WA, Green JR, Williams AF. Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. J Exp Med 1985; 162: 117-27.
25. Jung S, Kraemer S, Schluesener HJ, Huenig T, Toyka K, Hartung HP. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta. J Immunol 1992; 148: 3768-75.
26. Jung S, Schluesener HJ, Toyka K, Hartung HP. T cell vaccination does not induce resistance to experimental autoimmune neuritis. J Neuroimmunol 1991; 35: 1-11.
27. Jung S, Toyka K, Hartung HP. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2. Eur J Immunol 1995; 25: 1391-8.
28. Kadlubowski M, Hughes RAC. Identification of the neuritogen for experimental allergic neuritis. Nature 1979; 277: 140-1.
29. Kitamura K, Suzuki M, Uyemura K. Purification and partial characterization of two glycoproteins in bovine peripheral nerve myelin membrane. Biochim Biophys Acta 1976; 455: 806-16.
30. Lamb JR, Zanders ED, Sewell W, Crumpton MJ, Feldmann M, Owen MJ. Antigen-specific T cell unresponsiveness in cloned helper T cells mediated via the CD2 or CD3/Ti receptor pathways. Eur J Immunol 1987; 17: 1641-4.
31. Linington C, Izumo S, Suzuki M, Uyemura K, Meyermann R, Wekerle H. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol 1984; 133: 1946-50.
32. Liversidge J, Sewell HF, Forrester JV. Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology 1990; 71: 390-6.
33. Ludowyk PA, Willenborg DO, Parish CR. Selective localisation of neuro-specific T lymphocytes in the central nervous system. J Neuroimmunol 1992; 37: 237-50.
34. Male D, Pryce G, Hughes C, Lantos P. Lymphocyte migration into brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen. Cell Immunol 1990; 127: 1-11.
35. Meuer SC, Hussey RE, Fabbi M, Fox D, Acuto O, Fitzgerald KA, et al. An alternative pathway of T-cell activation: A functional role for the 50 kd TI1 sheep erythrocyte receptor protein. Cell 1984; 36: 897-906.
36. Norton WT, Poduslo SE. Myelination in rat brain: method of myelin isolation. J Neurochem 1973; 21: 749-57.
37. Ohno H, Nakamura T, Yagita H, Okumura K, Taniguchi M, Saito T. Induction of negative signal through CD2 during antigen-specific T cell activation. J Immunol 1991; 147: 2100-6.
38. Olee T, Weise M, Powers J, Brostoff S. A T cell epitope for experimental allergic neuritis is an amphipathic alpha-helical structure. J Neuroimmunol 1989; 21: 235-40.
39. Palacios R, Martinez-Maza O. Is the E receptor on human T lymphocytes a 'negative signal receptor'? J Immunol 1982; 129: 2479-85.
40. Powell HC, Olee T, Brostoff SW, Mizisin AP. Comparative histology of experimental allergic neuritis induced with minimum length neuritogenic peptides by adoptive transfer with sensitized cells or direct sensitization. J Neuropathol Exp Neurol 1991; 50: 658-74.
41. Qin L, Chavin KD, Lin J, Yagita H, Bromberg JS. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J Exp Med 1994; 179: 341-6.
42. Roark JH, Posselt AM, Campos L, Kim J, Chavin KD, Bromberg JS, et al. Prolongation of rat pancreatic islet allograft survival by anti-CD2 monoclonal antibody treatment. Transplantation 1992; 54: 1098-9.
43. Shimizu Y, Newman W, Tanaka Y, Shaw S. Lymphocyte interactions with endothelial cells. [Review]. Immunol Today 1992; 13: 106-12.
44. Smith ME, Forno LS, Hofmann WW. Experimental allergic neuritis in the Lewis rat. J Neuropathol Exp Neurol 1979; 38: 377-91.
45. Strigard K, Olsson T, Larsson P, Holmdahl R, Klareskog L. Modulation of experimental allergic neuritis in rats by in vivo treatment with monoclonal anti T cell antibodies. J Neurol Sci 1988; 83: 283-91.
46. Sun D, Branum K, Sun Q. Prevention of experimental autoimmune encephalomyelitis in Lewis rats by treatment with an anti-rat CD5 antibody (OX19). Cell Immunol 1992; 145: 263-71.
47. van der Meché FGA, Schmitz PIM, Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome [see comments]. N Engl J Med 1992; 326: 1123-9. Comment in: N Engl J Med 1992; 327: 816.
48. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 1992; 356: 63-6.